Founded in 1971, Össur has wide-ranging expertise in the development, production, and sale of non-invasive orthopaedics. After its first listing on the Iceland Stock Exchange in 1999, the Company expanded rapidly through a series of strategic acquisitions. Significant ongoing investment in research and innovation has also been central to its growth. A global leader in the field, Össur is determined to further strengthen its market position. The Company has been listed on the NASDAQ OMX Copenhagen Stock Exchange since 2009.
Headquartered in Iceland and employing a staff of around 2,200 across 18 locations, Össur has extensive operations in the Americas, Europe, and Asia, with numerous distributors in other markets.